What happened: A study found that patients using Wegovy have nearly five times the risk of sudden sight loss compared to those taking Ozempic. The risk is linked to 'eye strokes' caused by reduced blood flow to the optic nerve, likely a side effect of semaglutide, the active ingredient.
Why it matters:
- Increased risk of sudden vision loss affects patient safety for those using Wegovy.
- Users of semaglutide-based medications, including those for diabetes and weight management, may need closer monitoring.
MNN Take: Semaglutide medicines, used for blood sugar control and weight loss, can have rare but serious side effects on eye health. Awareness and medical supervision are important for patients prescribed these drugs.
Sources: Guardian UK